SCHEMBL28214966

SCHEMBL28214966

O=C(O)c1c[nH]nc1-c1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DCLRE1B Q9H816 1/20 0.47
▸ DHODH Q02127 3/20 0.46
▸ MAP2K4 P45985 1/20 0.46
▸ PIN1 Q13526 1/20 0.46
▸ KMO O15229 2/20 0.44
▸ NR4A1 P22736 1/20 0.43
▸ NR4A2 P43354 1/20 0.43
▸ NR4A3 Q92570 1/20 0.43
▸ NOTUM Q6P988 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ GRK6 P43250 1/20 0.41
▸ GPR35 Q9HC97 2/20 0.40
▸ PTGDR2 Q9Y5Y4 1/20 0.40
▸ CSNK2A2 P19784 1/20 0.40
▸ CSNK2B P67870 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8912951 0.86 JAK3 (0.40) DCLRE1BDHODHMAP2K4PIN1KMO
SCHEMBL27717172 0.84 ACMSD (0.50) DCLRE1BDHODHMAP2K4KMOKDM4E
SCHEMBL415485 0.82 KDM4E (0.55) MAP2K4NR4A2KDM4ESMN1; SMN2
SCHEMBL19663966 0.82 AKR1C2 (0.47) DHODHPIN1KMONR4A2NOTUM
SCHEMBL3519078 0.82 MCL1 (0.51) MAP2K4CSNK2A2CSNK2BKDM4E
SCHEMBL15750438 0.81 CA12 (0.45) DHODHMAP2K4NOTUMKDM4E
Ethylene SCHEMBL27448159 0.79 KDM4E (0.51) MAP2K4NR4A2KDM4ESMN1; SMN2
SCHEMBL25347360 0.77 TDP1 (0.59) GRK6IDO1SMN1; SMN2
SCHEMBL23294452 0.77 KMO (0.47) DHODHKMOIDO1
SCHEMBL8912952 0.76 TDO2 (0.46) MAP2K4PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107903251-A Pyrazole formylamine derivate as the TAAR conditioning agents for treating several conditions such as depression, diabetes and Parkinson's 霍夫曼-拉罗奇有限公司 2018-04-13 — — CN disclosed
Send feedback